FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

410919000: Drospirenone (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2004. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2466370019 Drospirenone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2472566012 Drospirenone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2466370019 Drospirenone (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2466370019 Drospirenone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2472566012 Drospirenone en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2472566012 Drospirenone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
52971000195117 drospirenone it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
67841000195113 Drospirenon de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
807661000172115 drospirénone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
807661000172115 drospirénone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
52971000195117 drospirenone it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
67841000195113 Drospirenon de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Drospirenone (substance) Is a Progesterone false Inferred relationship Existential restriction modifier (core metadata concept)
Drospirenone (substance) Is a Synthetic progestogen true Inferred relationship Existential restriction modifier (core metadata concept)
Drospirenone (substance) Has disposition Progestational hormone false Inferred relationship Existential restriction modifier (core metadata concept)
Drospirenone (substance) Is a Steroid hormone false Inferred relationship Existential restriction modifier (core metadata concept)
Drospirenone (substance) Is a Mineralocorticoid true Inferred relationship Existential restriction modifier (core metadata concept)
Drospirenone (substance) Is a Progestational hormone false Inferred relationship Existential restriction modifier (core metadata concept)
Drospirenone (substance) Has disposition Progesterone receptor agonist (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing drospirenone and ethinylestradiol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely drospirenone 2 milligram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing drospirenone and estradiol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely drospirenone 500 microgram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing drospirenone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Drospirenone 3 mg and ethinylestradiol 20 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Drospirenone 3 mg and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely drospirenone 500 microgram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Drospirenone 3 mg and ethinylestradiol 20 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Drospirenone 3 mg and ethinylestradiol 20 microgram oral tablet Has basis of strength substance (attribute) False Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely drospirenone 2 milligram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely drospirenone 2 milligram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely drospirenone 500 microgram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely drospirenone 500 microgram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing only ethinylestradiol 0.03 milligram and drospirenone 3 milligram/1 each oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing only ethinylestradiol 0.03 milligram and drospirenone 3 milligram/1 each oral tablet Has basis of strength substance (attribute) False Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Drospirenone 3 mg and ethinylestradiol 20 microgram oral tablet Has precise active ingredient False Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing drospirenone and estradiol in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing drospirenone and ethinylestradiol in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely drospirenone 2 milligram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient False Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely drospirenone 500 microgram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient False Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Drospirenone only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only drospirenone and estradiol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Drospirenone and ethinylestradiol only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Drospirenone and estradiol only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing only drospirenone and ethinylestradiol in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing only drospirenone and ethinylestradiol and levomefolic acid (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Drospirenone- and ethinylestradiol- and levomefolic acid-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Drospirenone 3 mg and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram oral tablet Has precise active ingredient True Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Drospirenone 3 mg and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram oral tablet Has basis of strength substance (attribute) True Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing only drospirenone and ethinylestradiol and levomefolic acid in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Drospirenone- and ethinylestradiol- and levomefolic acid-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely drospirenone 500 microgram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Drospirenone 3 mg and ethinylestradiol 20 microgram oral tablet Has basis of strength substance (attribute) True Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Drospirenone 3 mg and ethinylestradiol 20 microgram oral tablet Has precise active ingredient True Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely drospirenone 3 milligram and estetrol 14.2 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely drospirenone 3 milligram and estetrol 14.2 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Drospirenone- and estetrol-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing only drospirenone and estetrol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Drospirenone- and estetrol-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Drospirenone and estetrol only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Drospirenone 3 mg and ethinylestradiol (as ethinylestradiol betadex clathrate) 20 microgram oral tablet Has precise active ingredient True Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Drospirenone 3 mg and ethinylestradiol (as ethinylestradiol betadex clathrate) 20 microgram oral tablet Has basis of strength substance (attribute) True Drospirenone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2

This concept is not in any reference sets

Back to Start